Survival in patients with BRCA nuitation-positive platinum-sensitive recurrent ovarian cancer

被引：1
|
作者：
Hirst, Cerl
Parry, David
Alsop, Kathryn
deFazio, Anna
Fereday, Sian
Mitchell, Gillian
Bowtell, David
Emmanuel, Catherine
机构：
[1] AstraZeneca, Macclesfield, Cheshire, England
[2] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[3] Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, Sydney, NSW 2006, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e16519
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16519
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Nedaplatin and paclitaxel compared with carboplatin and paclitaxel for patients with platinum-sensitive recurrent ovarian cancer
    Ge, Li
    Li, Ning
    Yuan, Guang-Wen
    Sun, Yang-Chun
    Wu, Ling-Ying
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (06): : 1074 - 1082
  • [32] Increasing the chances for platinum-sensitive ovarian cancer patients
    Gonzalez, Antonio
    FUTURE ONCOLOGY, 2013, 9 (12) : 29 - 35
  • [33] Chemotherapy-free strategy for platinum-sensitive recurrent ovarian cancer
    Zhou, Qi
    Zou, Dongling
    Long, Xingtao
    LANCET ONCOLOGY, 2019, 20 (12): : E654 - E654
  • [34] Novel treatment options in platinum-sensitive recurrent ovarian cancer: A review
    Mullen, Mary M.
    Kuroki, Lindsay M.
    Thaker, Premal H.
    GYNECOLOGIC ONCOLOGY, 2019, 152 (02) : 416 - 425
  • [35] Olaparib in Platinum-Sensitive Ovarian Cancer
    Kaji, Daisuke
    Miura, Yuji
    Takano, Toshimi
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02): : 179 - 179
  • [36] Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy
    Tjokrowidjaja, Angelina
    Friedlander, Michael
    Lord, Sarah J.
    Asher, Rebecca
    Rodrigues, Manuel
    Ledermann, Jonathan A.
    Matulonis, Ursula A.
    Oza, Amit M.
    Bruchim, Ilan
    Huzarski, Tomasz
    Gourley, Charlie
    Harter, Philipp
    Vergote, Ignace
    Scott, Clare L.
    Meier, Werner
    Shapira-Frommer, Ronnie
    Milenkova, Tsveta
    Pujade-Lauraine, Eric
    Gebski, Val
    Lee, Chee K.
    EUROPEAN JOURNAL OF CANCER, 2021, 154 : 190 - 200
  • [37] Combination carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer
    Horowitz, N. S.
    Penson, R. T.
    Campos, S. M.
    Lee, J.
    Kendall, D. L.
    Krasner, C. N.
    Berlin, S. T.
    Roche, M.
    Duska, L. R.
    Matulonis, U. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] Platinum-free Interval May Predict Duration of Maintenance Bevacizumab and Survival in Platinum-sensitive Recurrent Ovarian Cancer
    Oh, Soo hyun
    Park, Soo jin
    Lee, Seungmee
    Lee, Seungho
    Kim, Hee seung
    IN VIVO, 2024, 38 (01): : 467 - 473
  • [39] Olaparib Outcomes in Patients with BRCA 1-2 Mutated, Platinum-Sensitive, Recurrent Ovarian Cancer in Croatia: A Retrospective Noninterventional Study
    Majic, Ana
    Mise, Branka Petric
    Matkovic, Visnja
    Belac Lovasic, Ingrid
    Katic, Kristina
    Canjko, Ivana
    Frobe, Ana
    Bajic, Zarko
    Vrdoljak, Eduard
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [40] A cost-effectiveness analysis of chemotherapy for patients with recurrent platinum-sensitive epithelial ovarian cancer
    Case, Ashley S.
    Rocconi, Rodney P.
    Partridge, Edward E.
    Straughn, J. Michael, Jr.
    GYNECOLOGIC ONCOLOGY, 2007, 105 (01) : 223 - 227
12345